These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36647217)

  • 21. Development of Macrolide Resistance and Reinfection in Refractory Mycobacterium avium Complex Lung Disease.
    Jhun BW; Kim SY; Moon SM; Jeon K; Kwon OJ; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
    Am J Respir Crit Care Med; 2018 Nov; 198(10):1322-1330. PubMed ID: 29877739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characteristics and treatment outcomes of patients with macrolide-resistant Mycobacterium avium complex pulmonary disease: a systematic review and meta-analysis.
    Park Y; Lee EH; Jung I; Park G; Kang YA
    Respir Res; 2019 Dec; 20(1):286. PubMed ID: 31852452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of emphysema on the prognosis of Mycobacterium avium complex pulmonary disease.
    Takasaka N; Hosaka Y; Fukuda T; Shinfuku K; Chida K; Shibata S; Kojima A; Hasegawa T; Yamada M; Yamanaka Y; Seki A; Seki Y; Ishikawa T; Kuwano K
    Respir Med; 2022 Feb; 192():106738. PubMed ID: 35051876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intermittent Antibiotic Therapy for Recurrent Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease.
    Jhun BW; Moon SM; Kim SY; Park HY; Jeon K; Kwon OJ; Huh HJ; Ki CS; Lee NY; Chung MJ; Lee KS; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural course of the nodular bronchiectatic form of Mycobacterium Avium complex lung disease: Long-term radiologic change without treatment.
    Park TY; Chong S; Jung JW; Park IW; Choi BW; Lim C; Lee CU; Kim YS; Choi HW; Choi JC
    PLoS One; 2017; 12(10):e0185774. PubMed ID: 28968457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effective treatment for clarithromycin-resistant Mycobacterium avium complex lung disease.
    Adachi Y; Tsuyuguchi K; Kobayashi T; Kurahara Y; Yoshida S; Kagawa T; Hayashi S; Suzuki K
    J Infect Chemother; 2020 Jul; 26(7):676-680. PubMed ID: 32171660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment outcomes of refractory MAC pulmonary disease treated with drugs with unclear efficacy.
    Jo KW; Kim S; Lee JY; Lee SD; Kim WS; Kim DS; Shim TS
    J Infect Chemother; 2014 Oct; 20(10):602-6. PubMed ID: 24981714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment outcome of combination therapy including clarithromycin for Mycobacterium avium complex pulmonary disease.
    Kim EY; Chi SY; Oh IJ; Kim KS; Kim YI; Lim SC; Kim YC; Kwon YS
    Korean J Intern Med; 2011 Mar; 26(1):54-9. PubMed ID: 21437163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of intermittent maintenance therapy after successful treatment of Mycobacterium avium complex lung disease.
    Asakura T; Nakagawa T; Suzuki S; Namkoong H; Morimoto K; Ishii M; Kurashima A; Betsuyaku T; Ogawa K; Hasegawa N;
    J Infect Chemother; 2019 Mar; 25(3):218-221. PubMed ID: 30172726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microbiologic Outcome of Interventions Against Mycobacterium avium Complex Pulmonary Disease: A Systematic Review.
    Diel R; Nienhaus A; Ringshausen FC; Richter E; Welte T; Rabe KF; Loddenkemper R
    Chest; 2018 Apr; 153(4):888-921. PubMed ID: 29410162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic effects of various initial combinations of chemotherapy including clarithromycin against Mycobacterium avium complex pulmonary disease.
    Hasegawa N; Nishimura T; Ohtani S; Takeshita K; Fukunaga K; Tasaka S; Urano T; Ishii K; Miyairi M; Ishizaka A
    Chest; 2009 Dec; 136(6):1569-1575. PubMed ID: 19542259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variables associated with antibiotic treatment tolerance in patients with Mycobacterium avium complex pulmonary disease.
    Marmor M; Sharifi H; Jacobs S; Fazeli K; Ruoss S
    Respir Res; 2024 Mar; 25(1):123. PubMed ID: 38468274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term, low-dose erythromycin monotherapy for Mycobacterium avium complex lung disease: a propensity score analysis.
    Komiya K; Kurashima A; Ihi T; Nagai H; Matsumoto N; Mizunoe S; Ishii H; Takahashi O; Ohta K; Kudoh S; Kadota J
    Int J Antimicrob Agents; 2014 Aug; 44(2):131-5. PubMed ID: 24948577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First line treatment selection modifies disease course and long-term clinical outcomes in Mycobacterium avium complex pulmonary disease.
    Fukushima K; Kitada S; Komukai S; Kuge T; Matsuki T; Kagawa H; Tsujino K; Miki M; Miki K; Kida H
    Sci Rep; 2021 Jan; 11(1):1178. PubMed ID: 33441977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of chest CT in patients with Mycobacterium avium complex pulmonary disease.
    Fujiuchi S; Matsumoto H; Yamazaki Y; Nakao S; Takahashi M; Satoh K; Takeda A; Okamoto K; Fujita Y; Fujikane T; Shimizu T
    Respiration; 2003; 70(1):76-81. PubMed ID: 12584395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microbiological Cure at Treatment Completion Is Associated With Longer Survival in Patients With Mycobacterium avium Complex Pulmonary Disease.
    Kim JY; Park J; Choi Y; Kim TS; Kwak N; Yim JJ
    Chest; 2023 Nov; 164(5):1108-1114. PubMed ID: 37423256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the spectrum of radiologic and clinical manifestations of pulmonary disease caused by Mycobacterium avium complex and Mycobacterium xenopi.
    Carrillo MC; Patsios D; Wagnetz U; Jamieson F; Marras TK
    Can Assoc Radiol J; 2014 Aug; 65(3):207-13. PubMed ID: 24325924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Impact of Trehalose Dimycolate on the Clinical Course of
    Lee J; Fujiwara N; Kim JY; Kang M; Yang JS; Yim JJ; Whang J; Kwak N
    Ann Am Thorac Soc; 2024 Jul; 21(7):1015-1021. PubMed ID: 38285897
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment Outcomes after Discontinuation of Ethambutol due to Adverse Events in
    Kwon YS; Kwon BS; Kim OH; Park YE; Shim TS; Chong YP; Jo KW
    J Korean Med Sci; 2020 Mar; 35(9):e59. PubMed ID: 32141249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The natural history of non-cavitary nodular bronchiectatic Mycobacterium avium complex lung disease.
    Kwon BS; Lee JH; Koh Y; Kim WS; Song JW; Oh YM; Lee SD; Lee SW; Lee JS; Lim CM; Choi CM; Huh JW; Hong SB; Shim TS; Jo KW
    Respir Med; 2019 Apr; 150():45-50. PubMed ID: 30961950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.